News-Detail

Dr. Marcel Binz from the Institute for Human-Centered AI at Helmholtz Munich has received a Starting Grant from the European Research Council (ERC). Through the MIDAS project, he will develop large-scale computational models designed to simulate,…

Proteinbausteine mit synthetischen Proteinstrukturen als RNA-Transporter werden mithilfe generativer KI entworfen_Helles Bild

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Synthetic Transfer Vehicles (STVs), an entirely new class of RNA transporters. To do so, they combined naturally occurring protein building blocks with…

Closeup timelapse of layered muscle fibers diminishing over time illustrating severe muscle atrophy in cancer cachexia.

Researchers at Helmholtz Munich, the Heidelberg Faculty of Medicine at Heidelberg University, the German Center for Diabetes Research (DZD) and the Technical University of Munich (TUM), have identified a previously unknown mechanism that can drive…

The CureGPX4 Foundation has named Prof. Marcus Conrad, Director of the Institute of Metabolism and Cell Death at Helmholtz Munich, as the first recipient of the Raghav Prize for Rare Disease and Citizen Science. The prize recognizes his research into…

Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstraße 1
85764 Neuherberg
Deutschland

Verhandlungsverfahren ohne TW / Negotiated procedure without prior publication

…

Helmholtz Zentrum München
Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)
Ingolstädter Landstraße 1
85764 Neuherberg
Deutschland

Verhandlungsverfahren ohne TW / Negotiated procedure without prior publication

…

Marcel Binz Receives ERC Starting Grant for MIDAS

AI-Designed Proteins Enable a New Generation of RNA Transporters

Cancer Cachexia: How a Tumor Protein Drives Wasting in the Body

Marcus Conrad Receives Inaugural Raghav Prize for Rare Disease Research

Mängelbeseitigung BMA G3525

Mängelbeseitigung BMA G3534